ClinConnect ClinConnect Logo
Search / Trial NCT00847314

Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients

Launched by BAYER · Feb 18, 2009

Trial Information

Current as of July 05, 2025

Completed

Keywords

Hypogonadism Abdominal Obesity Physical Exercise Testosterone

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male patients \> 35yrs
  • Waist Circumference \> 102cm
  • Clinically and biochemically confirmed hypogonadism (testosterone group)
  • Willingness to attempt weight optimization
  • Exclusion Criteria:
  • Androgen dependent carcinoma of the prostate or male mammary gland, past or present history of liver tumours
  • hypersensitivity towards the active pharmaceutical ingredient or other ingredients.

About Bayer

Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.

Locations

Many Locations, , Germany

Patients applied

0 patients applied

Trial Officials

Bayer Study Director

Study Director

Bayer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials